Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B

Core Promoter ◽

Basal Core Promoter ◽

Hbsag Loss ◽

Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients

Scientific Reports ◽

10.1038/srep17950 ◽

2015 ◽

Vol 5 (1) ◽

Cited By ~ 12

Author(s):

Linlin Yan ◽

Henghui Zhang ◽

Hui Ma ◽

Di Liu ◽

Wei Li ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B Virus ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Deep Sequencing ◽

Core Promoter ◽

Basal Core Promoter ◽

B Virus ◽

Clinical features of hepatitis B e-antigen positive chronic hepatitis B patients co-existing precore and/or basal core promoter mutations

Future Virology ◽

10.2217/fvl-2018-0091 ◽

2018 ◽

Vol 13 (10) ◽

pp. 687-695

Author(s):

Li-Bo Yan ◽

Xiao-Qiong Tang ◽

Qing-Bo Zhang ◽

Xia Zhu ◽

Lang Bai ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Clinical Features ◽

Core Promoter ◽

Basal Core Promoter ◽

Hepatitis B E Antigen ◽

Positive Chronic Hepatitis ◽

Promoter Mutations

Peg‐interferon alpha add‐on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg positive chronic hepatitis B naïve patients

Journal of Viral Hepatitis ◽

10.1111/jvh.13571 ◽

2021 ◽

Author(s):

Jing Li ◽

Lihong Qu ◽

Xuehua Sun ◽

Yanhong Liu ◽

Qiming Gong ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Interferon Alpha ◽

Hbsag Loss ◽

Precore and basal core promoter mutations in Asian American patients with hepatitis B e antigen-positive chronic hepatitis B

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12193 ◽

2012 ◽

Vol 37 (4) ◽

pp. 464-472 ◽

Cited By ~ 6

Author(s):

P. Vutien ◽

H. N. Trinh ◽

K. Nguyen ◽

R. T. Garcia ◽

H. A. Nguyen ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Asian American ◽

Core Promoter ◽

Basal Core Promoter ◽

Hepatitis B E Antigen ◽

Positive Chronic Hepatitis ◽

Promoter Mutations

Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy

Liver International ◽

10.1111/j.1478-3231.2004.00893.x ◽

2004 ◽

Vol 24 (1) ◽

pp. 9-15 ◽

Cited By ~ 11

Author(s):

Chih-Lin Lin ◽

Li-Ying Liao ◽

Chaur-Shine Wang ◽

Pei-Jer Chen ◽

Ming-Yang Lai ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B Virus ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Core Promoter ◽

Basal Core Promoter ◽

Lamivudine Therapy ◽

B Virus ◽

Promoter Gene ◽

Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long‑term therapy before HBsAg loss in non-cirrhotic HBeAg‑negative chronic hepatitis B

Antiviral Therapy ◽

10.3851/imp3261 ◽

2018 ◽

Vol 23 (8) ◽

pp. 711

Author(s):

George V Papatheodoridis ◽

Eirini I Rigopoulou ◽

Margarita Papatheodoridi ◽

Kalliopi Zachou ◽

Vassilios Xourafas ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Term Therapy ◽

Hbsag Loss ◽

Long Term Therapy ◽

Negative Chronic Hepatitis

Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B

Journal of Hepatology ◽

10.1016/j.jhep.2020.08.039 ◽

2020 ◽

Author(s):

Maria Pfefferkorn ◽

Tina Schott ◽

Stephan Böhm ◽

Danilo Deichsel ◽

Christin Felkel ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Hbsag Loss ◽

Clinical Features of Chronic Hepatitis B in Treatment-naive Asian Patients With Positive HBeAg and Coexisting Precore and/or Basal Core Promoter Mutations

Journal of Clinical Gastroenterology ◽

10.1097/mcg.0000000000000664 ◽

2017 ◽

Vol 51 (3) ◽

pp. 261-267 ◽

Cited By ~ 2

Author(s):

Calvin Q. Pan ◽

Erhei Dai ◽

Kalyan R. Bhamidimarri ◽

Zheng Zeng ◽

Paley Yin

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Clinical Features ◽

Core Promoter ◽

Basal Core Promoter ◽

Asian Patients ◽

Treatment Naïve ◽

Promoter Mutations ◽

Positive Hbeag

DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B

Antiviral Therapy ◽

10.3851/imp3256 ◽

2018 ◽

Vol 23 (8) ◽

pp. 677-685 ◽

Cited By ~ 19

Author(s):

George V Papatheodoridis ◽

Eirini I Rigopoulou ◽

Margarita Papatheodoridi ◽

Kalliopi Zachou ◽

Vassilios Xourafas ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Term Therapy ◽

Hbsag Loss ◽

Long Term Therapy ◽

Negative Chronic Hepatitis

Effect of multiple mutations in the core promoter and pre-core/core region of hepatitis B virus genome on the response to interferon in e antigen-positive chronic hepatitis B

Journal of Gastroenterology and Hepatology ◽

10.1046/j.1440-1746.2001.02451.x ◽

2001 ◽

Vol 16 (4) ◽

pp. 393-398 ◽

Cited By ~ 6

Author(s):

Xinxin Zhang ◽

Yongnian Han ◽

Zhimeng Lu ◽

Jian Gao ◽

Zhenghui Luo ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B Virus ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Core Promoter ◽

Virus Genome ◽

Core Region ◽

The Core ◽

B Virus ◽